SteriMed

Medical Waste Processing Systemssterimedsystems.com

SteriMed is a US-based, privately held company founded in 1993 that develops systems to safely process infectious medical waste for healthcare and related regulated waste generators.

Company typePrivate
Founded1993
HeadquartersFarmington Hills, United States
Headcount11–50
GTM typeB2B
OfferingHardware or Manufacturing

What SteriMed does

SteriMed is a privately held US company founded in 1993 and headquartered in Farmington Hills, Michigan, that develops systems for the safe processing of infectious medical waste. The company operates with a workforce of 11–50 employees and serves healthcare and adjacent facilities that generate regulated biohazardous waste streams requiring compliant treatment and disposal.

The company's core offering centers on processing technology for infectious medical waste — proprietary handling systems designed to render contaminated materials safe for downstream disposal. Specific technical architecture, treatment modality (e.g., autoclaving, chemical disinfection, or thermal alternatives), throughput capacity, and equipment footprint are not disclosed in the available source material. No patents, trademarks, certifications, or regulatory filings were captured in the input, so the proprietary depth of the processing system cannot be independently verified.

SteriMed's business model and revenue mechanics are not documented in the available data. The firmographic profile (specialized B2B services, healthcare vertical, small employee base, 30+ year operating history) implies a niche services-plus-equipment model selling into regulated healthcare waste generators under recurring collection or processing contracts, but pricing structure, contract duration, customer mix, and geographic reach cannot be confirmed from the supplied sources. Separately, the input material aggregates a dot-health.org article about men's health telehealth that references the sterimedsystems.com domain; this content is unrelated to the firm's medical waste business and is treated as a referral-link artifact rather than a reflection of SteriMed's actual operations.

SteriMed firmographics

Firmographics

Name: SteriMed
Website: https://sterimedsystems.com
Company type: Private
Founded year: 1993
Headcount range: 11–50 employees
Short description: SteriMed is a US-based, privately held company founded in 1993 that develops systems to safely process infectious medical waste for healthcare and related regulated waste generators.
Ownership category
akta.pro rank

SteriMed industry classification

Industry

Product category: Medical Waste Processing Systems
NAICS: Hazardous Waste Treatment and Disposal (562211), Waste Treatment and Disposal (56221)
SIC: Hazardous Waste Management (4955), Refuse Systems (4953)
akta.pro primary industry: Medical & Biohazard Waste Disposal (RMW/Sharps) (IMAIAFAJ)
akta.pro secondary industries: Medical & Biohazardous Waste Management (RMW, Sharps, Pathological) (EUAIAFAE), Medical / Infectious Waste Treatment & Disposal (Autoclave + Incineration + Final Disposal) (EUAIACAJ), Medical Waste Management & Biohazard Disposal Systems (Regulated Waste, Liners, Containers) (HLAHANAI)

Keywords

Medical waste processing
Infectious waste treatment
Biohazard waste systems
Medical sterilization equipment
Healthcare waste management

Where SteriMed is headquartered

Location

Headquarters

HQ city: Farmington Hills
HQ country: United States
HQ region: North America

Markets served

SteriMed business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

SteriMed product offering

Product offering

Core offering

SteriMed develops a system that safely processes infectious medical waste. The company designs and provides technology used by healthcare and laboratory operators to treat biohazardous waste streams. Founded in 1993 and headquartered in Farmington Hills, Michigan, SteriMed serves as a specialized provider of medical waste processing solutions.

Differentiator

Problem solved

Functional benefit

Products and services

Infectious Medical Waste Processing System A system developed by SteriMed that safely processes infectious medical waste, designed for healthcare and laboratory operators that generate biohazardous waste.

Companies that use SteriMed

Customer profile

Segments1 record

Ideal customer profiles1 record

SteriMed technology and API

Technology

Technology focussed Yes

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

SteriMed partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights1 record

SteriMed competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

SteriMed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SteriMed leadership team

Management profile

Number of profiles

SteriMed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SteriMed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SteriMed

What does SteriMed do?

When was SteriMed founded?

SteriMed was founded in 1993. It employs 11 to 50 people.

Where is SteriMed based?

SteriMed is headquartered in Farmington Hills, United States, in the North America region.

Does SteriMed have an API?

No public API is recorded for SteriMed.

What industry is SteriMed in?

SteriMed's product category is Medical Waste Processing Systems. Its primary akta.pro industry code is IMAIAFAJ, Medical & Biohazard Waste Disposal (RMW/Sharps), with a secondary code of EUAIAFAE, Medical & Biohazardous Waste Management (RMW, Sharps, Pathological). Its NAICS code is 562211 and its SIC code is 4955.